SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 12/12/16 Veru Inc. 10-K 9/30/16 85:9.6M |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.25M 2: EX-10.11 Material Contract HTML 31K 3: EX-10.16 Material Contract HTML 55K 4: EX-10.21 Material Contract HTML 64K 5: EX-10.7 Material Contract HTML 34K 6: EX-10.9 Material Contract HTML 31K 7: EX-21 Subsidiaries List HTML 25K 8: EX-23.1 Consent of Experts or Counsel HTML 24K 9: EX-31.1 Certification -- §302 - SOA'02 HTML 32K 10: EX-31.2 Certification -- §302 - SOA'02 HTML 32K 11: EX-32.1 Certification -- §906 - SOA'02 HTML 25K 18: R1 Document And Entity Information HTML 52K 19: R2 Consolidated Balance Sheets HTML 120K 20: R3 Consolidated Balance Sheets (Parenthetical) HTML 40K 21: R4 Consolidated Statements Of Income HTML 82K 22: R5 Consolidated Statements Of Stockholders? Equity HTML 68K 23: R6 Consolidated Statements Of Stockholders? Equity HTML 36K (Parenthetical) 24: R7 Consolidated Statements Of Cash Flows HTML 106K 25: R8 Nature Of Business And Significant Accounting HTML 131K Policies 26: R9 Earnings Per Share HTML 62K 27: R10 Inventory HTML 73K 28: R11 Line of Credit HTML 39K 29: R12 Operating Leases And Rental Expense HTML 66K 30: R13 Income Taxes HTML 232K 31: R14 Equity And Share-Based Payments HTML 159K 32: R15 Stock Repurchase Program HTML 65K 33: R16 Employee Benefit Plan HTML 33K 34: R17 Industry Segments And Financial Information About HTML 114K Foreign And Domestic Operations 35: R18 Contingent Liabilities HTML 29K 36: R19 Dividends HTML 31K 37: R20 Quarterly Financial Data HTML 120K 38: R21 Subsequent Events HTML 61K 39: R22 Nature Of Business And Significant Accounting HTML 188K Policies (Policy) 40: R23 Nature Of Business And Significant Accounting HTML 99K Policies (Tables) 41: R24 Earnings Per Share (Tables) HTML 56K 42: R25 Inventory (Tables) HTML 73K 43: R26 Operating Leases And Rental Expense (Tables) HTML 58K 44: R27 Income Taxes (Tables) HTML 215K 45: R28 Equity And Share-Based Payments (Tables) HTML 133K 46: R29 Stock Repurchase Program (Tables) HTML 64K 47: R30 Industry Segments And Financial Information About HTML 96K Foreign And Domestic Operations (Tables) 48: R31 Quarterly Financial Data (Tables) HTML 118K 49: R32 Subsequent Events (Tables) HTML 37K 50: R33 Nature Of Business And Significant Accounting HTML 94K Policies (Narrative) (Details) 51: R34 Nature Of Business And Significant Accounting HTML 45K Policies (Components Of Accounts Receivable) (Details) 52: R35 Nature Of Business And Significant Accounting HTML 32K Policies (Summary Of Components Of Allowance For Doubtful Accounts) (Details) 53: R36 Nature Of Business And Significant Accounting HTML 56K Policies (Summary Of Significant Customers) (Details) 54: R37 Nature Of Business And Significant Accounting HTML 36K Policies (Summary Of Depreciation And Amortization) (Details) 55: R38 Earnings Per Share (Schedule Of Earnings Per HTML 63K Share, Basic And Diluted) (Details) 56: R39 Inventory (Components Of Inventory) (Details) HTML 40K 57: R40 Inventory (Change In Inventory Reserve) (Details) HTML 34K 58: R41 Line of Credit (Narrative) (Details) HTML 61K 59: R42 Operating Leases And Rental Expense (Narrative) HTML 67K (Details) 60: R43 Operating Leases And Rental Expense (Schedule Of HTML 31K Operating Lease Expense, Including Real Estate Taxes And Insurance) (Details) 61: R44 Operating Leases And Rental Expense (Schedule Of HTML 43K Future Minimum Payments Under Leases) (Details) 62: R45 Income Taxes (Narrative) (Details) HTML 48K 63: R46 Income Taxes (Schedule Of Income Before Income HTML 33K Taxes, By Jurisdictions) (Details) 64: R47 Income Taxes (Reconciliation Of Income Tax Expense HTML 65K (Benefit)) (Details) 65: R48 Income Taxes (Summary Of Federal And State Income HTML 59K Tax Provision (Benefit)) (Details) 66: R49 Income Taxes (Significant Components Of Deferred HTML 67K Tax Assets And Liabilities) (Details) 67: R50 Income Taxes (Schedule Of Deferred Tax Amounts HTML 40K Classified In Balance Sheets) (Details) 68: R51 Income Taxes (Changes In Valuation Allowance For HTML 34K Deferred Tax Assets) (Details) 69: R52 Equity And Share-Based Payments (Narrative) HTML 166K (Details) 70: R53 Equity And Share-Based Payments (Weighted Average HTML 36K Assumptions For Options Granted) (Details) 71: R54 Equity And Share-Based Payments (Summary Of Stock HTML 55K Options Outstanding And Exercisable) (Details) 72: R55 Equity And Share-Based Payments (Summary Of HTML 52K Non-Vested Stock Activity) (Details) 73: R56 Stock Repurchase Program (Narrative) (Details) HTML 36K 74: R57 Stock Repurchase Program (Total Repurchase HTML 30K Transactions) (Details) 75: R58 Stock Repurchase Program (Schedule Of Repurchase HTML 40K Activity) (Details) 76: R59 Employee Benefit Plan (Details) HTML 42K 77: R60 Industry Segments And Financial Information About HTML 86K Foreign And Domestic Operations (Schedule Of Operations By Geographic Area) (Details) 78: R61 Contingent Liabilities (Narrative) (Details) HTML 26K 79: R62 Dividends (Narrative) (Details) HTML 34K 80: R63 Quarterly Financial Data (Details) HTML 50K 81: R64 Subsequent Events (Narrative) (Details) HTML 109K 82: R65 Subsequent Events (Schedule of Pro forma of HTML 34K Combined Entity) (Details) 84: XML IDEA XML File -- Filing Summary XML 150K 83: EXCEL IDEA Workbook of Financial Reports XLSX 91K 12: EX-101.INS XBRL Instance -- c894-20160930 XML 2.60M 14: EX-101.CAL XBRL Calculations -- c894-20160930_cal XML 140K 15: EX-101.DEF XBRL Definitions -- c894-20160930_def XML 579K 16: EX-101.LAB XBRL Labels -- c894-20160930_lab XML 1.19M 17: EX-101.PRE XBRL Presentations -- c894-20160930_pre XML 997K 13: EX-101.SCH XBRL Schema -- c894-20160930 XSD 175K 85: ZIP XBRL Zipped Folder -- 0000863894-16-000032-xbrl Zip 179K
Exhibit 1011 |
FIRST AMENDMENT TO EMPLOYMENT AGREEMENT
THIS FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (this "Amendment") is dated effective as of July 18, 2016, by and between THE FEMALE HEALTH COMPANY, a Wisconsin corporation (the "Company"), and MARTIN TAYLER (the "Executive").
RECITALS
The Company and Executive are parties to that certain Employment Agreement dated as of April 5, 2016 (the "Existing Agreement"). Capitalized terms used herein without definition shall have the respective meanings ascribed thereto in the Existing Agreement.
In accordance with Section 10 of the Existing Agreement, the undersigned desire to amend the Existing Agreement as set forth in this Amendment.
AGREEMENTS
In consideration of the foregoing recitals and the mutual representations, warranties, covenants and agreements set forth herein, and intending to be legally bound hereby, the parties agree as follows:
1. Sections 1 and 2 of the Existing Agreement are amended by replacing the term "Mergers" with "APP Merger" in each and every place where such term appears. |
2. No Other Changes. Except as expressly provided herein, the Existing Agreement shall remain unchanged and in full force and effect. |
3. Counterparts. This Amendment may be executed in two or more counterparts, all of which shall be considered originals of one and the same agreement and shall become effective when one or more counterparts have been signed by each of the parties hereto and delivered to the other parties. Signatures delivered by facsimile or by e-mail in portable document format (PDF) shall be binding for all purposes hereof. |
[Signature page follows.]
IN WITNESS WHEREOF, the parties hereto have executed this First Amendment to Employment Agreement as of the date first above written.
COMPANY:
THE FEMALE HEALTH COMPANY
BY /s/ O.B. Parrish
Name: O.B. Parrish
Title: Chief Executive Officer
EXECUTIVE:
/s/ Martin Tayler
[Signature Page to First Amendment to Employment Agreement]
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 12/12/16 | 8-K | ||
For Period end: | 9/30/16 | |||
7/18/16 | 8-K, CORRESP, PRER14A | |||
4/5/16 | 8-K | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/01/24 Veru Inc. 10-K/A 9/30/23 96:18M 12/08/23 Veru Inc. 10-K 9/30/23 88:14M 12/05/22 Veru Inc. 10-K 9/30/22 87:13M 12/02/21 Veru Inc. 10-K 9/30/21 96:9.5M 12/10/20 Veru Inc. 10-K 9/30/20 100:9.9M |